History Mission Strategic plan Role The FAMHP also ensures that … Our core business Our organisation Organisation chart Our vision and values Vision and ambition Values Commitments by federal administrations Our stakeholders Partners FAMHP customer charter Partners receiving financial support from the FAMHP The FAMHP and European projects Disclaimer Transparency Social media Conditions for reuse (Creative Commons-0 licence)
26/02/2026 Unavailability of Holoxan 1 g powder for solution for injection for intravenous use: recommendations for physicians specialists and hospital pharmacists
06/02/2026 "Paracetamol challenge" : a reminder of the risks associated with overdosing and rules for proper use